study

(redirected from Open-label study)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to Open-label study: Prospective study, Double blind study

study

1. a drawing, sculpture, etc., executed for practice or in preparation for another work
2. a musical composition intended to develop one aspect of performing technique
3. Theatre a person who memorizes a part in the manner specified

study

A drawing executed as an educational exercise, produced as a preliminary to a final work or made record observations.
See also: Design drawing

study

1. A room or alcove of a house or apartment used primarily as a place for reading, writing, and study. It often embodies the features of a private office and private library.
2. A preliminary sketch or drawing to facilitate the development of a design.
References in periodicals archive ?
Patient questionnaire responses indicated 50% of subjects in the open-label study used PrEP correctly, a significantly better adherence rate than the 42% seen in the earlier double-blind study.
Another group of investigators conducted a 6-month open-label study of 541 patients diagnosed with a bipolar disorder (66.
The open-label study was an extension of three 8-week placebo-controlled trials that demonstrated escitalopram (Lexapro) to be effective in the short-term treatment of generalized anxiety disorder.
This multicenter, open-label study enrolled patients with a current or previous diagnosis of LGS aged 2 to 60 years old.
SAP302 is a single-arm, open-label study that enrolled 76 adult patients who presented in the emergency room with moderate-to-severe acute pain associated with trauma or injury.
M2 EQUITYBITES-January 7, 2016-SillaJen starts multinational randomised Phase three open-label study of Pexa-Vec
M2 PHARMA-January 7, 2016-SillaJen starts multinational randomised Phase three open-label study of Pexa-Vec
In an open-label study of children with multiple molluscum contagiosum, Dr.
Patients maintained on Zenvia 30/10 mg demonstrated statistically significant incremental improvement in their CNS-LS scores over the additional 12-week treatment period of the open-label study (p<0.
This randomized-controlled study follows an open-label study with RUCONEST given once weekly, which was published in the peer reviewed journal Allergy in November 2012.
This open-label study was an extension of one of the two pivotal randomised controlled studies which formed the basis for approval in Europe.